Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PCNA | P12004 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 3/20 | 0.37 |
| ▸ | THRA | P10827 | 2/20 | 0.37 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | TAAR5 | O14804 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3682170 | 1.00 | PPARG (0.39) | PPARGNR1I2AGTR2MEN1BLM | |
| SCHEMBL6063658 | 0.77 | LTA4H (0.45) | THRBTAAR5TAAR1 | |
| SCHEMBL21899391 | 0.76 | SLC7A5 (0.55) | TAAR1 | |
| SCHEMBL38225 | 0.76 | SLC7A5 (0.55) | TAAR1 | |
| SCHEMBL38224 | 0.76 | SLC7A5 (0.55) | TAAR1 | |
| SCHEMBL6062363 | 0.75 | F2 (0.50) | FFAR1TAAR5TAAR1 | |
| SCHEMBL8745470 | 0.75 | THRA (0.42) | PPARGNR1I2AGTR2MEN1BLM | |
| SCHEMBL7263477 | 0.75 | TAAR5 (0.48) | MEN1KMT2ATAAR5TAAR1 | |
| SCHEMBL7277625 | 0.75 | PCNA (0.38) | PPARGPCNATHRBTHRAFFAR1 | |
| SCHEMBL9715457 | 0.73 | MEN1 (0.46) | MEN1KMT2ATHRBTAAR5TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1461028-A4 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | UNIV CALIFORNIA (US) | 2007-07-25 | — | — | EP | claimed |
| WO-2004098506-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-11-18 | — | — | WO | claimed |
| EP-1461028-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | The Regent of the University of California (US) | 2004-09-29 | — | — | EP | claimed |
| US-20030229062-A1 | Treatments for age-related macular degeneration (AMD) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-12-11 | — | — | US | claimed |
| US-20030162758-A1 | Treatment for age-related macular degeneration (AMD) | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2003-08-28 | — | — | US | claimed |
| WO-2003049685-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-06-19 | — | — | WO | claimed |
| US-20100047330-A1 | TREATMENT FOR DARK ADAPTATION | THE REGENTS OF THE UNIVERSTIY OF CALIFORNIA | 2010-02-25 | — | — | US | disclosed |
| US-7470660-B2 | Treatment for dark adaptation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-12-30 | — | — | US | disclosed |
| US-7470659-B2 | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-12-30 | — | — | US | disclosed |
| EP-1461028-A4 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | UNIV CALIFORNIA (US) | 2007-07-25 | — | — | EP | disclosed |
| US-20050282750-A1 | Treatment for dark adaptation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-12-22 | — | — | US | disclosed |
| WO-2005091909-A2 | METHODS TO INCREASE REVERSE CHOLESTEROL TRANSPORT IN THE RETINAL PIGMENT EPITHELIUM (RPE) AND BRUCH’S MEMBRANE (BM) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-10-06 | — | — | WO | disclosed |
| US-20040266663-A1 | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and bruch's membrane (BM) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-12-30 | — | — | US | disclosed |
| WO-2004098506-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-11-18 | — | — | WO | disclosed |
| EP-1461028-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | The Regent of the University of California (US) | 2004-09-29 | — | — | EP | disclosed |
| US-20030229062-A1 | Treatments for age-related macular degeneration (AMD) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-12-11 | — | — | US | disclosed |
| US-20030162758-A1 | Treatment for age-related macular degeneration (AMD) | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2003-08-28 | — | — | US | disclosed |
| WO-2003049685-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-06-19 | — | — | WO | disclosed |